Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) shot up 0.6% on Tuesday . The stock traded as high as $1.58 and last traded at $1.56. 83,368 shares were traded during mid-day trading, a decline of 18% from the average session volume of 101,227 shares. The stock had previously closed at $1.55.
Analysts Set New Price Targets
Separately, HC Wainwright reiterated a "buy" rating and issued a $4.00 price target on shares of Vivani Medical in a report on Monday, May 19th.
Read Our Latest Stock Analysis on VANI
Vivani Medical Stock Performance
The stock has a 50-day simple moving average of $1.22 and a 200 day simple moving average of $1.15. The company has a market cap of $92.41 million, a P/E ratio of -3.63 and a beta of 2.89.
Vivani Medical (NASDAQ:VANI - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Sell-side analysts anticipate that Vivani Medical, Inc. will post -0.41 earnings per share for the current fiscal year.
Institutional Trading of Vivani Medical
Institutional investors have recently modified their holdings of the company. Connective Capital Management LLC grew its position in Vivani Medical by 796.2% during the first quarter. Connective Capital Management LLC now owns 162,098 shares of the company's stock worth $170,000 after buying an additional 144,010 shares in the last quarter. Wealthedge Investment Advisors LLC boosted its holdings in shares of Vivani Medical by 238.8% in the 1st quarter. Wealthedge Investment Advisors LLC now owns 125,033 shares of the company's stock valued at $131,000 after purchasing an additional 88,132 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of Vivani Medical in the 4th quarter valued at $66,000. Finally, Northern Trust Corp lifted its stake in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company's stock valued at $83,000 after acquiring an additional 11,540 shares during the last quarter. 6.78% of the stock is currently owned by institutional investors.
About Vivani Medical
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
